Target intelligence / Profile preview

Dirofilaria immitis glutamate-gated chloride channel alpha 3B subunit (DiGluClα3B) (DiGluClα3B)

Target
DiGluClα3B
Molecular classification
Ion channel, Ligand-gated ion channel, Cys-loop receptor, Glutamate-gated chloride channel
01

Overview

DiGluClα3B is a subunit of the glutamate-gated chloride channel (GluCl) found in the parasitic nematode Dirofilaria immitis, which causes heartworm disease in dogs and cats [4, 14]. It belongs to the Cys-loop ligand-gated ion channel superfamily and is a splice variant of the avr-14 gene [18, 20]. This receptor is a primary molecular target for macrocyclic lactones, such as ivermectin and moxidectin, which are widely used as heartworm preventatives [4, 5]. When these drugs bind to the DiGluClα3B subunit, they act as potent agonists, causing the channel to open and allow an influx of chloride ions [18, 22]. This leads to hyperpolarization of the parasite's neurons and muscles, resulting in flaccid paralysis and eventual death or expulsion of the worm [5, 18]. Because GluCls are absent in vertebrates, these drugs exhibit high selective toxicity toward the parasite [15, 17]. However, the emergence of macrocyclic lactone resistance in D. immitis populations has made the study of DiGluClα3B and its polymorphisms a critical area of veterinary research [4, 17]. Understanding the pharmacological properties and expression patterns of this subunit is essential for developing next-generation anthelmintics to combat resistant heartworm strains [1, 19].

Other names
AVR-14BDi-AVR-14BDirofilaria immitis GluCl alpha 3BDi-GLC-1Glutamate-gated chloride channel alpha 3B
02

Mechanism of action

Agonist of the glutamate-gated chloride channel, leading to hyperpolarization and paralysis of the parasite [4, 18].

03

Biological functions

Inhibitory neurotransmissionLocomotionMuscle paralysisSignal transduction
04

Disease associations

InfectionHeartworm diseaseDirofilariasis
05

Safety considerations

Neurotoxicity in MDR1-deficient dogs [5]Drug resistance in parasite populations [4, 17]
06

Interacting drugs

Ivermectin

5 more in the full profile.

07

Biomarkers

avr-14 gene polymorphisms [18, 23]GluCl alpha 3B expression levels [1, 23]

Beyond the preview

Go deeper on Dirofilaria immitis glutamate-gated chloride channel alpha 3B subunit (DiGluClα3B) (DiGluClα3B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dirofilaria immitis glutamate-gated chloride channel alpha 3B subunit (DiGluClα3B) (DiGluClα3B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call